Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
84 studies found for:    contact dermatitis
Show Display Options
Rank Status Study
1 Completed Effect of Tetrix on Alleviation of Burning,Itching Associated With Lesions of Contact Dermatitis
Condition: Contact Dermatitis
Interventions: Device: Tetrix;   Device: Placebo
2 Enrolling by invitation Immune Reactions in Contact Dermatitis Affected Skin
Condition: Allergic Contact Dermatitis
Intervention: Other: Patch tests
3 Completed Safety, Tolerability, and Efficacy of 21 Days Dermal Application of MRX-6 on Mild to Moderate Contact Dermatitis
Condition: Allergic Contact Dermatitis
Interventions: Drug: MRX-6;   Drug: Steroid
4 Unknown  Bariederm Cream in Chronic Contact Dermatitis
Condition: Contact Dermatitis
Intervention: Device: bariederm cream
5 Completed NI-0801 in Allergic Contact Dermatitis
Condition: Allergic Contact Dermatitis
Interventions: Drug: Placebo;   Drug: NI-0801
6 Unknown  Pathophysiological Study of Allergic Contact Dermatitis to Para-Phenylenediamine (PPD). Analysis of Cellular and Molecular Targets in Skin Inflammation
Condition: Allergic Contact Dermatitis
Intervention:
7 Recruiting Evaluation of Safety and Efficacy of BBI-2000 in Treating and Preventing Contact Dermatitis
Condition: Contact Dermatitis
Interventions: Drug: BBI-2000;   Drug: Vehicle;   Other: Multiple treatments
8 Withdrawn Vulvar Contact Dermatitis Resulting From Urine Incontinence
Conditions: Urinary Incontinence;   Vulvar Pruritus;   Vulvar Contact Dermatitis
Intervention: Other: Questionnaires, gynecological exam , vaginal smear, and measurement of urine leakage
9 Completed Clinical Evaluation of the 3 Allergens: Methyldibromoglutharonitrile, Parthenolide and Goldnatriumthiosulphate
Condition: Allergic Contact Dermatitis
Intervention: Drug: Goldnatriomthiosulphate, MDBGN, parthenolide
10 Unknown  Clinical Evaluation of T.R.U.E. Test Allergens in Children an Adolescents
Condition: Allergic Contact Dermatitis
Intervention: Drug: T.R.U.E. Test Panel 3.2
11 Unknown  Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study
Condition: Contact Dermatitis
Intervention: Biological: Mercury, Aluminum, Palladium
12 Completed
Has Results
Study of Apremilast in Atopic or Contact Dermatitis
Conditions: Atopic Dermatitis;   Allergic Contact Dermatitis
Intervention: Drug: Apremilast
13 Withdrawn Clinical Evaluation of T.R.U.E. TEST Panel 3.2 in Children and Adolescents
Condition: Contact Dermatitis
Intervention: Biological: Patch Test
14 Completed Clinical Evaluation of Lyral® Dose Response Study
Condition: Contact Dermatitis
Intervention: Biological: Lyral®
15 Unknown  Nickel Desensitization Using Topical Therapy
Condition: Allergic Contact Dermatitis
Intervention: Drug: Calcipotriol, Betamethasone, Calcipotriol & Betamethasone
16 Completed Clinical Evaluation of Bacitracin
Condition: Allergic Contact Dermatitis
Intervention: Drug: bacitracin (allergen)
17 Completed
Has Results
Clinical Evaluation of T.R.U.E. TEST® : Safety and Efficacy
Condition: Contact Dermatitis
Intervention: Biological: T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens
18 Completed Clinical Evaluation of T.R.U.E. TEST® Panel 3.2 Allergens: Dose Response
Condition: Contact Dermatitis
Intervention: Biological: T.R.U.E. TEST® Skin Patch Test: Dose Response Allergens
19 Enrolling by invitation A Phase I, Single-Center Study of PDC-APB in Healthy Volunteers
Condition: Contact Dermatitis
Interventions: Drug: PDC-APB;   Drug: Placebo
20 Completed
Has Results
A Study To Assess Safety And Effectiveness Of Medrol In Contact Dermatitis In Indian Patients
Condition: Dermatitis, Contact
Intervention: Drug: Tablet Methylprednisolone (4 or 16 mg)

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.